These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 18228160)
61. Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification. Paramita P; Shilpa R; Nandeesh BN; Yasha TC; Vani S Neurol India; 2024 Jan; 72(1):96-101. PubMed ID: 38443009 [TBL] [Abstract][Full Text] [Related]
62. Gonadotroph adenoma with secondary hypersecretion of testosterone. Chamoun R; Layfield L; Couldwell WT World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183 [TBL] [Abstract][Full Text] [Related]
63. Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation in vitro and in vivo. Murasawa S; Kageyama K; Sugiyama A; Ishigame N; Niioka K; Suda T; Daimon M Mol Cell Endocrinol; 2014 Aug; 394(1-2):37-46. PubMed ID: 25011056 [TBL] [Abstract][Full Text] [Related]
64. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Sano T; Kovacs K; Asa SL; Smyth HS Virchows Arch A Pathol Anat Histopathol; 1990; 417(4):361-7. PubMed ID: 2173251 [TBL] [Abstract][Full Text] [Related]
65. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study. Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980 [TBL] [Abstract][Full Text] [Related]
66. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas. Sanno N; Teramoto A; Matsuno A; Itoh J; Takekoshi S; Osamura RY Acta Neuropathol; 1996; 91(3):263-8. PubMed ID: 8834538 [TBL] [Abstract][Full Text] [Related]
67. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases. Berg KK; Scheithauer BW; Felix I; Kovacs K; Horvath E; Klee GG; Laws ER Neurosurgery; 1990 Mar; 26(3):397-403. PubMed ID: 1690866 [TBL] [Abstract][Full Text] [Related]
68. Simultaneous production of the alpha-subunit of glycoprotein hormones and other hormones in pituitary adenomas. Jautzke G Pathol Res Pract; 1988 Sep; 183(5):601-5. PubMed ID: 2467268 [TBL] [Abstract][Full Text] [Related]
69. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Buurman H; Saeger W Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024 [TBL] [Abstract][Full Text] [Related]
70. Effect of Gonadotropin and Adrenocorticotropic Hormone Secretion on Invasiveness of Clinically Nonfunctioning Pituitary Adenomas: A Cell Culture Study. Usui S; Hama S; Tominaga A; Kinoshita Y; Kurisu K World Neurosurg; 2016 Dec; 96():578-584.e1. PubMed ID: 27601155 [TBL] [Abstract][Full Text] [Related]
71. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway. Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702 [TBL] [Abstract][Full Text] [Related]
72. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. La Rosa S; Celato N; Uccella S; Capella C Virchows Arch; 2000 Sep; 437(3):264-9. PubMed ID: 11037346 [TBL] [Abstract][Full Text] [Related]
73. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors. Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675 [TBL] [Abstract][Full Text] [Related]
74. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors. Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140 [TBL] [Abstract][Full Text] [Related]
75. EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas. Fukuoka H; Cooper O; Ben-Shlomo A; Mamelak A; Ren SG; Bruyette D; Melmed S J Clin Invest; 2011 Dec; 121(12):4712-21. PubMed ID: 22105169 [TBL] [Abstract][Full Text] [Related]
76. Immunohistochemical studies of human FSH producing pituitary adenomas. Osamura RY; Watanabe K Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):61-8. PubMed ID: 2453972 [TBL] [Abstract][Full Text] [Related]
77. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356 [TBL] [Abstract][Full Text] [Related]
78. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas. Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002 [TBL] [Abstract][Full Text] [Related]
79. Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone: A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma. McDonald WC; Banerji N; McDonald KN; Ho B; Macias V; Kajdacsy-Balla A Arch Pathol Lab Med; 2017 Jan; 141(1):104-112. PubMed ID: 27227698 [TBL] [Abstract][Full Text] [Related]
80. Hormonal aggressiveness according to the expression of cellular markers in corticotroph adenomas. Lim JS; Lee MK; Choi E; Hong N; Il Jee S; Kim SH; Lee EJ Endocrine; 2019 Apr; 64(1):147-156. PubMed ID: 30474823 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]